{
  "id": "mhgap#risk_safety_12dafca9",
  "content": "4\nAre there concurrent MNS conditions?\nA ssess for other concurrent MNS conditions according to the\nmhGAP-IG Master Chart (MC)\nPlease note persons with EPILEPSY are at higher risk for DEPRESSION, DISORDERS\nDUE TO SUBSTANCE USE. CHILDREN AND ADOLSCENTS MAY HAVE ASSOCIATED MENTAL\nAND BEHAVIOURAL DISORDERS. SUBSTANCE USE DISORDERS\nGo to PROTOCOL 1\nIF THERE IS IMMINENT RISK\nOF SUICIDE, ASSESS AND\nMANAGE before continuing\nto Protocol. Go to SUI.\nEPI 2 Management\nPROTOCOL\n1\nProvide psychoeducation to the person and carers (2.1)\nInitiate antiepileptic medications (2.3)\nPromote functioning in daily activities (2.2)\nSpecial populations\nNote that interventions are different for EPILEPSY in these populations\nHIV\nWOMAN OF CHILDBEARING AGE CHILD / ADOLESCENT PERSON LIVING WITH HIV\nConcern: Risk of antiepileptic medication to fetus/child Concern: Effect of antiepileptic medication Concern: Drug interactions between antiepileptic\non development and/or behavior medications and antiretrovirals\nAdvise folate (5 mg/day) to prevent neural tube For those with a developmental disorder, When available, refer to specific drug interactions\ndefects, in ALL women of childbearing age. manage the condition. Go to CMH. for person’s antiretroviral regimen and antiepileptic\nmedication.\nAVOID VALPROATE. For children with behavioural disorder, avoid",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "high",
    "topics": [
      "risk_safety",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety 4\nAre there concurrent MNS conditions?\nA ssess for other concurrent MNS conditions according to the\nmhGAP-IG Master Chart (MC)\nPlease note persons with EPILEPSY are at higher risk for DEPRESSION, DISORDERS\nDUE TO SUBSTANCE USE. CHILDREN AND ADOLSCENTS MAY HAVE ASSOCIATED MENTAL\nAND BEHAVIOURAL DISORDERS. SUBSTANCE USE DISORDERS\nGo to PROTOCOL 1\nIF THERE IS IMMINENT RISK\nOF SUICIDE, ASSESS AND\nMANAGE before continuing\nto Protocol. Go to SUI.\nEPI 2 Management\nPROTOCOL\n1\nProvide psychoeducation to the person and carers (2.1)\nInitiate antiepileptic medications (2.3)\nPromote functioning in daily activities (2.2)\nSpecial populations\nNote that interventions are different for EPILEPSY in these populations\nHIV\nWOMAN OF CHILDBEARING AGE CHILD / ADOLESCENT PERSON LIVING WITH HIV\nConcern: Risk of antiepileptic medication to fetus/child Concern: Effect of antiepileptic medication Concern: Drug interactions between antiepileptic\non development and/or behavior medications and antiretrovirals\nAdvise folate (5 mg/day) to prevent neural tube For those with a developmental disorder, When available, refer to specific drug interactions\ndefects, in ALL women of childbearing age. manage the condition. Go to CMH. for person’s antiretroviral regimen and antiepileptic\nmedication.\nAVOID VALPROATE. For children with behavioural disorder, avoid 4\nare there concurrent mns conditions? a ssess for other concurrent mns conditions according to the\nmhgap-ig master chart (mc)\nplease note persons with epilepsy are at higher nguy cơ for trầm cảm, disorders\ndue to substa..."
}